Trivium Point Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.37M | Sell |
7,562
-402
| -5% | -$179K | 0.37% | 76 |
|
|
2025
Q1 | $3.86M | Sell |
7,964
-305
| -4% | -$148K | 0.48% | 56 |
|
|
2024
Q4 | $3.33M | Buy |
8,269
+555
| +7% | +$223K | 0.42% | 75 |
|
|
2024
Q3 | $3.82M | Sell |
7,714
-407
| -5% | -$201K | 0.53% | 57 |
|
|
2024
Q2 | $3.81M | Buy |
8,121
+1,280
| +19% | +$600K | 0.57% | 50 |
|
|
2024
Q1 | $2.86M | Buy |
6,841
+1,945
| +40% | +$813K | 0.62% | 51 |
|
|
2023
Q4 | $1.99M | Buy |
4,896
+3,399
| +227% | +$1.38M | 0.48% | 64 |
|
|
2023
Q3 | $517K | Buy |
1,497
+51
| +4% | +$17.6K | 0.14% | 143 |
|
|
2023
Q2 | $509K | Buy |
1,446
+30
| +2% | +$10.6K | 0.14% | 151 |
|
|
2023
Q1 | $446K | Buy |
+1,416
| New | +$446K | 0.12% | 153 |
|